OUR FUTURE HEALTH
The advancement of health in the UK for the public benefit
Objects
THE CHARITY'S OBJECTS ARE RESTRICTED SPECIFICALLY ONLY FOR THE PUBLIC BENEFIT TO PRESERVE AND ADVANCE HUMAN HEALTH AND ADVANCE EDUCATION IN PARTICULAR BY ENGAGING IN, ENCOURAGING AND SUPPORTING:2.1.1 INVESTIGATIONS INTO THE SEPARATE AND COMBINED EFFECTS OF GENETIC, ENVIRONMENTAL (INCLUDING LIFESTYLE, PHYSIOLOGICAL AND ENVIRONMENTAL EXPOSURES) AND OTHER FACTORS ON HUMAN HEALTH AND WELFARE AND ON THE RISK, EARLY DETECTION AND CAUSATION OF DISEASES IN THE HUMAN POPULATION;2.1.2 THE ESTABLISHMENT, HOLDING, OPERATION, MANAGEMENT, PROMOTION, SUPPORT, EXPANSION, IMPROVEMENT AND SAFEGUARDING OF A COLLECTION OF BIOMEDICAL, BIOCHEMICAL, EPIDEMIOLOGICAL, GENETIC AND OTHER DATA AND BLOOD AND OTHER BIOLOGICAL AND BIOCHEMICAL SAMPLES OBTAINED AND DEVELOPED THROUGH, FOR THE PURPOSE OF AND/OR IN CONNECTION WITH SOME OR ALL OF THE INVESTIGATIONS REFERRED TO IN ARTICLE 2.1.1 AND PERTAINING TO A COHORT OF HUMAN PARTICIPANTS, FOR USE IN A RESEARCH, KNOWLEDGE AND INFORMATION RESOURCE;2.1.3 THE DISCOVERY, INVENTION, IMPROVEMENT, DEVELOPMENT AND APPLICATION OF TREATMENTS, CURES, DIAGNOSTICS AND OTHER MEDICINAL AGENTS, METHODS AND PROCESSES THAT MAY IN ANY WAY RELIEVE ILLNESS, DISEASE, DISABILITY OR DISORDERS OF WHATEVER NATURE IN HUMANS;2.1.4 RESEARCH INTO BIOLOGICAL AND MEDICAL SCIENCES AND OTHER DISCIPLINES WHICH MAYCONTRIBUTE TO THE IMPROVEMENT OF HUMAN HEALTH AND WELFARE ('BIOSCIENCES');AND2.1.5 THE STUDY AND UNDERSTANDING OF ANY OF THE BIOSCIENCES.NOTHING IN THESE ARTICLES SHALL AUTHORISE AN APPLICATION OF THE PROPERTY OF THE CHARITY FOR PURPOSES WHICH ARE NOT CHARITABLE IN ACCORDANCE WITH SECTION 7 OF THE CHARITIES AND TRUSTEE INVESTMENT (SCOTLAND) ACT 2005 OR SECTION 2 OF THE CHARITIES ACT (NORTHERN IRELAND) 2008.
Financial health, per its FY2025 accounts
The accounts state that the charity reported a net expenditure loss of £12.9m for the year ended 31 March 2025, resulting in unrestricted reserves decreasing from £44.0m to £31.0m. Per the trustees' report, the organization maintains a strong surplus against its stated reserves policy target of three months of committed costs less committed revenues, supported by a healthy year-end cash position of £10.6m.
What the accounts disclose
“£340,001 - £350,000 1”
“Of the employees whose emoluments exceed £60,000, 138 (2024: 76) have retirement benefits accruing under defined contribution schemes.” — page 25
“Income from government grants 54,160,200”
“Our Future Health will maintain a target level of free reserves equivalent to at least three months of committed costs less committed revenues.”
“Our Future Health also has a wholly owned trading subsidiary which is limited by share capital. The trading subsidiary is called Our Future Health Trading Ltd (company number 12599493)”
Policies the charity declares
- Bullying and harassment policy and procedures
- Complaints policy and procedures
- Conflicting interests
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Safeguarding policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/03/2025
- Government income: £54,160,200 — grants £54,160,200 (1); 55% of the £97,922,773 total gross income on the same return
- Employees paid over £60,000: 140 (£60,001–£70,000: 31; £70,001–£80,000: 28; £80,001–£90,000: 25; £90,001–£100,000: 20; £100,001–£110,000: 9; £110,001–£120,000: 6; £120,001–£130,000: 6; £130,001–£140,000: 7; £140,001–£150,000: 1; £150,001–£200,000: 4; £200,001–£250,000: 2; £300,001–£350,000: 1)
- Has a trading subsidiary
Self-declared on the annual return for the financial year ending 31/03/2024
- Government income: £62,000,000 — grants £62,000,000 (1); 77% of the £80,268,925 total gross income on the same return
- Employees paid over £60,000: 76 (£60,001–£70,000: 22; £70,001–£80,000: 13; £80,001–£90,000: 15; £90,001–£100,000: 3; £100,001–£110,000: 4; £110,001–£120,000: 6; £120,001–£130,000: 6; £130,001–£140,000: 1; £140,001–£150,000: 1; £150,001–£200,000: 3; £200,001–£250,000: 1; £250,001–£300,000: 1)
- Has a trading subsidiary
Self-declared on the annual return for the financial year ending 31/03/2023
- Government income: £12,639,181 — grants £12,639,181 (1); 48% of the £26,518,753 total gross income on the same return
- Employees paid over £60,000: 38 (£60,001–£70,000: 15; £70,001–£80,000: 2; £80,001–£90,000: 5; £90,001–£100,000: 3; £100,001–£110,000: 3; £110,001–£120,000: 1; £120,001–£130,000: 1; £130,001–£140,000: 2; £140,001–£150,000: 1; £150,001–£200,000: 4; £200,001–£250,000: 1)
- Has a trading subsidiary
In the news
- New study charts the health of nearly 2 million UK adults in Our Future Health
- Phenomic profiles and disease patterns of 1.9 million participants from Our Future Health
- Only 55.5% of UK adults meet physical activity guidelines, Our Future Health study finds
- Is Our Future Health safe? DNA, NHS data and £10 voucher explained
- Our future health is at stake
- Join Our Future Health today
- What a 15-minute heart-related test can tell us about our future health
- Cardiometabolic disorder comorbidity within affective disorders: analysis of 1.6 million participants in the Our Future Health cohort
Funders the charity credits
- Asthma + Lung UK
- Alnylam
UK research funding (UKRI Gateway to Research)
- Accelerating Detection of Disease Core Programme (1 April 2023 onwards)
- Rhythms in Disease- Determining Circadian Clock Mechanism in Asthma
- Consolidating the UK Longitudinal Linkage Collaboration for the longitudinal research community.
- UK Longitudinal Linkage Collaboration: the transformative Trusted Research Environment for the UK longitudinal research community
- GENETIC VARIATION, IRON AND LATER LIFE HEALTH OUTCOMES
- SOCGEN: Combining Social Science and Molecular Genetic Research to Examine Inequality and the Life Course
- Health Research from Home: advancing population research using smartphones and wearables
- Population Research UK Coordination Hub
- Cohort and Longitudinal Studies Enhancement Resources (CLOSER) - 1 October 2024 to 30 September 2028
- The Avon Longitudinal Study of Parents and Children (ALSPAC) 2024-2029
Advertised salaries (public job ads)
- Director of Data Operations and Governance
- Senior Agile Coach
- Engineering Manager
- General Counsel
- Staff Software Engineer - Data Platforms
- Software Engineer - (Typescript & Node)
- Senior Data Engineer
- Senior Commercial Strategy & Insights Analyst
Structured financials (annual return, FY ending 31/03/2025)
Trustees
- Professor Sir John Irving Bellchair
- Adrian Nevil Hennah
- Ciaran Martin CB
- Dr Glenn Wells
- Dr Timothy Charles Peakman
- John Deanfield
- Kemal Zulfiqar Malik
- MARY-JANE CALAM
- Peter Alan Chambre
- Professor Sir Harpal Singh Kumar
- Richard George Sexton
- Sally Osman
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £97.9m | £110.9m |
| 31/03/2024 | £80.3m | £85.4m |
| 31/03/2023 | £26.5m | £35.7m |
| 31/03/2022 | £64.8m | £6.5m |
| 31/03/2021 | £4.4m | £4.4m |
Common questions
Is OUR FUTURE HEALTH financially healthy?
Per its FY2025 accounts: The accounts state that the charity reported a net expenditure loss of £12.9m for the year ended 31 March 2025, resulting in unrestricted reserves decreasing from £44.0m to £31.0m. Per the trustees' report, the organization maintains a strong surplus against its stated reserves policy target of three months of committed costs less committed revenues, supported by a healthy year-end cash position of £10.6m. Its FY2025 accounts were audited by Saffery LLP.
What does the highest-paid employee of OUR FUTURE HEALTH earn?
Per its FY2025 accounts, the highest-paid employee was in the £340,001 - £350,000 band, and 138 employees earned over £60,000.
Who funds OUR FUTURE HEALTH?
Funders whose own accounts filings name OUR FUTURE HEALTH as a grant recipient include BRITISH HEART FOUNDATION, Asthma and Lung UK.
Known funders
| Funder | Year | Amount | Purpose (as stated by the funder) |
|---|---|---|---|
| BRITISH HEART FOUNDATION | FY2025 | £5.0m | Research |
| Asthma and Lung UK | FY2024 | £90k | Non-Research grant |
Government & lottery funding
| Funder | Date | Amount | Purpose |
|---|---|---|---|
| UK government | 22/01/2024 | £54.2m | Accelerating Detection of Disease Core Programme (1 April 2023 onwards) |
| UK government | 22/01/2024 | £62.0m | Accelerating Detection of Disease Core Programme (1 April 2023 onwards) |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE NUFFIELD FOUNDATION | 2 | £1.0m |
| This Day Foundation | 1 | £4.4m |
| THE MOHN WESTLAKE FOUNDATION | 1 | £1.3m |
| IMPETUS - THE PRIVATE EQUITY FOUNDATION | 1 | £516k |
| THE YOUTH ENDOWMENT FUND CHARITABLE TRUST | 1 | £513k |
| THE HEALTH FOUNDATION | 1 | £496k |
| THE WESTMINSTER FOUNDATION | 1 | £300k |
| THE PEARS FAMILY CHARITABLE FOUNDATION | 1 | £300k |
Charities like this
- YOUR VOICE IN HEALTH AND SOCIAL CARE
- FUTURE-FIT FOUNDATION
- FULL FACT
- FUTURE DREAMS TRUST LIMITED
- SHEFFIELD FUTURES
- BRITISH FUTURE
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| OUR FUTURE HEALTH | £97.9m | £340,001 - £350,000 | 138 | unclear | — | no doubt |
| YOUR VOICE IN HEALTH AND SOCIAL CARE | £1.2m | — | 0 | unclear | — | no doubt |
| FUTURE-FIT FOUNDATION | £107k | — | 0 | within | — | no doubt |
| FULL FACT | £3.1m | £110,000 - £119,999 | 9 | above | — | no doubt |
| FUTURE DREAMS TRUST LIMITED | £2.1m | — | — | below | — | no doubt |
| SHEFFIELD FUTURES | £1.3m | £70,001 - £80,000 | 1 | above | — | no doubt |